The table (refined data from [14]) shows the mutants associated with resistance for imatinib, ponatinib, and dasatinib. حسب J. Roadnight Sheehan (20141887)

الموضوعات:

The enzyme states and their relative weights within the system in quasi-equilibrium. حسب J. Roadnight Sheehan (20141887)

الموضوعات:

A heat map to compare the associated resistances outlined in Table 1 and [14] with the IRP values. حسب J. Roadnight Sheehan (20141887)

الموضوعات:

How the variation in inhibitor concentration throughout one day affects the value of IC₅₀/(IC₅₀ + [R]) for different Abl1 inhibitors. حسب J. Roadnight Sheehan (20141887)

الموضوعات:

We define the term “inhibitory reduction prowess” (IRP) as the percentage by which the product formation rate is reduced by from the initial point before inhibitor is introduced to... حسب J. Roadnight Sheehan (20141887)

الموضوعات:

The values calculated for the inhibitor dissociation constant, as detailed in Eqs 10 and 11 and approximated values for the binding rate constants of the inhibitors. حسب J. Roadnight Sheehan (20141887)

الموضوعات:

Values for the calculation of the time-dependent drug concentrations in the system based on observed data found and derived from a variety of sources. حسب J. Roadnight Sheehan (20141887)

الموضوعات:

To bridge two naming conventions (one more suitable to mathematical notation and one more conventional in enzymology), the table matches the rate constants as described in Eq 2 to... حسب J. Roadnight Sheehan (20141887)

الموضوعات:

A cartoon of the simplified model of the Abl1 enzyme system. حسب J. Roadnight Sheehan (20141887)

الموضوعات:

Residence times, <i>t</i>_R, of the inhibitor molecules unbinding from the wild-type from [41] and the rates of calculated from them. حسب J. Roadnight Sheehan (20141887)

الموضوعات:

Various outputs from the model with the drug imatinib. حسب J. Roadnight Sheehan (20141887)

الموضوعات:

Different calculated values for indication of resistance for each combination of mutant and inhibitor against IRP. حسب J. Roadnight Sheehan (20141887)

الموضوعات:

Generation of 70Z/3 overexpressing cell lines. حسب Jeffrey L. Kurkewich (3044211)

الموضوعات: "…Cell Biology…"

EF-24 treatment modulates gene expression in THP-1 cells. حسب Ajeet P. Singh (22298432)

الموضوعات:

PD-1 deficiency does obviously not change B cell and CD11b⁺ myeloid cell IHC staining in livers following <i>S</i>. <i>japonicum</i> infection. حسب Liaoxun Lu (179293)

miR-1469 expression in melanoma does not significantly alter susceptibility of tumor cells to apoptosis via regulation of MCL1. حسب Mallory J. DiVincenzo (11372420)

الموضوعات:

Data Sheet 1_The CML experience to elucidate the role of innate T-cells as effectors in the control of residual cancer cells and as potential targets for cancer therapy.pdf حسب Amandine Decroos (20222913)

"…This was particularly the case when considering iNKT cells for which surface-expression level of PD-1 even decreased relative to healthy control subjects. …"

Differentially expressed genes from pseudo-bulk analysis and the KEGG pathways of myeloid, lymphoid and fibroblast subsets. حسب Abishek Balakumar (20189865)

Presentation_1_Tristetraprolin limits age-related expansion of myeloid-derived suppressor cells.pptx حسب Kyu Hwan Kwack (5588222)

"…As TTP expression is known to decrease with age in myeloid cells, we used TTP-deficient (TTPKO) mice to model aged mice to study TTP regulation in age-related myelopoiesis. …"

Table_2_A Novel Single Cell RNA-seq Analysis of Non-Myeloid Circulating Cells in Late Sepsis.xlsx حسب Dijoia B. Darden (9019154)

"…</p>Conclusion<p>Circulating non-myeloid cells display a unique transcriptomic pattern late after sepsis. …"